Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Helen McShane

Showing results (31-40 of 218) with videos related to

Pageof 22
Sort By:
Microbiology Spectrum|January 15, 2017
Clinical Testing of Tuberculosis Vaccine CandidatesMark Hatherill, Dereck Tait, Helen McShane
Transactions of the Royal Society of Tropical Medicine and Hygiene|February 1, 2015
Aerosol immunisation for TB: matching route of vaccination to route of infectionZita-Rose Manjaly Thomas, Helen McShane
The New England Journal of Medicine|September 29, 2021
SARS-CoV-2 Human Challenge Studies. ReplyGarth Rapeport, Christopher Chiu, Helen McShane
Health Research Policy and Systems|February 20, 2022
Rapid research response to the COVID-19 pandemic: perspectives from a National Institute for Health Biomedical Research CentreLorna R Henderson, Helen McShane, Vasiliki Kiparoglou
Journal of Bioethical Inquiry|June 19, 2009
A New Vaccine for Tuberculosis: The Challenges of Development and DeploymentHelen A Fletcher, Tony Hawkridge, Helen McShane
International Journal of Epidemiology|May 14, 2016
Effects of MVA85A vaccine on tuberculosis challenge in animals: systematic reviewHelen McShane, Mark Hatherill, Willem Hanekom, et al.
Lancet (London, England)|July 2, 2013
Tuberculosis vaccine trials - Authors' replyMichele Tameris, Mark Hatherill, Hassan Mahomed, et al.
Scientific Reports|May 11, 2026
Domain arrangement-driven immunogenicity of a computationally designed mRNA vaccine targeting PPE68, IrtA, and PE9 of Mycobacterium tuberculosisTheerawat Dorbutr, Elena Stylianou, Helen McShane, et al.
Expert Review of Vaccines|December 27, 2019
Mucosal delivery of tuberculosis vaccines: a review of current approaches and challengesElena Stylianou, Matthew J Paul, Rajko Reljic, et al.
Microbial Pathogenesis|December 22, 2012
Vaccination against tuberculosis: how can we better BCG?Jonathan M Pitt, Simon Blankley, Helen McShane, et al.
Pageof 22

Showing results (31-40 of 218) with videos related to

Sort By:
Pageof 22
Microbiology Spectrum|January 15, 2017
Clinical Testing of Tuberculosis Vaccine CandidatesMark Hatherill, Dereck Tait, Helen McShane
Transactions of the Royal Society of Tropical Medicine and Hygiene|February 1, 2015
Aerosol immunisation for TB: matching route of vaccination to route of infectionZita-Rose Manjaly Thomas, Helen McShane
The New England Journal of Medicine|September 29, 2021
SARS-CoV-2 Human Challenge Studies. ReplyGarth Rapeport, Christopher Chiu, Helen McShane
Health Research Policy and Systems|February 20, 2022
Rapid research response to the COVID-19 pandemic: perspectives from a National Institute for Health Biomedical Research CentreLorna R Henderson, Helen McShane, Vasiliki Kiparoglou
Journal of Bioethical Inquiry|June 19, 2009
A New Vaccine for Tuberculosis: The Challenges of Development and DeploymentHelen A Fletcher, Tony Hawkridge, Helen McShane
International Journal of Epidemiology|May 14, 2016
Effects of MVA85A vaccine on tuberculosis challenge in animals: systematic reviewHelen McShane, Mark Hatherill, Willem Hanekom, et al.
Lancet (London, England)|July 2, 2013
Tuberculosis vaccine trials - Authors' replyMichele Tameris, Mark Hatherill, Hassan Mahomed, et al.
Scientific Reports|May 11, 2026
Domain arrangement-driven immunogenicity of a computationally designed mRNA vaccine targeting PPE68, IrtA, and PE9 of Mycobacterium tuberculosisTheerawat Dorbutr, Elena Stylianou, Helen McShane, et al.
Expert Review of Vaccines|December 27, 2019
Mucosal delivery of tuberculosis vaccines: a review of current approaches and challengesElena Stylianou, Matthew J Paul, Rajko Reljic, et al.
Microbial Pathogenesis|December 22, 2012
Vaccination against tuberculosis: how can we better BCG?Jonathan M Pitt, Simon Blankley, Helen McShane, et al.
Pageof 22